Clinical Trial Update: Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Amimestrocel Injection to prevent severe oral mucositis in hematopoietic stem cell transplant patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Mucositis
• Oral Mucositis
• Stomatitis

Drugs mentioned

• Amimestrocel Injection (amimestrocel)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Oral Mucositis, Stomatitis | Phase 2 | Status: RECRUITING